CyFlow™ CD3 PE-Cy7

Antigen: | CD3 |
Alternative Name: | Leu4, T3 |
Clone: | SK7 |
Application: | Flow cytometry |
Format/Fluorochrome: | PE-Cy7 |
Laser: | Blue, Green, Yellow |
Target Species: | Human, Non-Human Primates |
Field of Interest: | Immunophenotyping |
Species of Origin: | Mouse |
Regulatory Status: | RUO |
Clonality: | monoclonal |
Emission Maximum: | 785 nm |
Excitation Maximum: | 496 nm, 565 nm |
Isotype: | IgG1 |
HLDA Workshop | HLDA II—WS Code T118 HLDA III—WS Code T492 |
Quantity | 100 tests |
Volume | 0.4 |
Immunogen | Human thymocytes |
Background Information | CD3 complex is crucial in transducing antigen-recognition signals into the cytoplasm of T cells and in regulating the cell surface expression of the TCR complex. T cell activation through the antigen receptor (TCR) involves the cytoplasmic tails of the CD3 subunits CD3γ, CD3 δ, CD3ε and CD3ζ. These CD3 subunits are structurally related members of the immunoglobulins superfamily encoded by closely linked genes on human chromosome 11. The CD3 components have long cytoplasmic tails that associate with cytoplasmic signal transduction molecules. This association is mediated at least in part by a double tyrosine-based motif present in a single copy in the CD3 subunits. CD3 may play a role in TCR-induced growth arrest, cell survival and proliferation. The CD3 antigen is present on 68-82% of normal peripheral blood lymphocytes, 65-85% of thymocytes and Purkinje cells in the cerebellum. It is never expressed on B or NK cells. Decreased percentages of T lymphocytes may be observed in some autoimmune diseases. |
Usage | The reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 4·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests. |
Storage Buffer | The reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide. |
Storage | Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze. |
Stability | Do not use after expiration date stamped on vial label. |
| Wood GS, Burns BF, Dorfman RF, Warnke RA: The immunohistology of non‑T cells in the acquired immunodeficiency syndrome. Am·J·Pathol. 1985·Sep; 120(3):371‑9. <·PMID:·3898858·> | Li B, Wang H, Dai J, Ji J, Qian W, Zhang D, Hou S, Guo Y: Construction and characterization of a humanized anti‑human CD3 monoclonal antibody 12F6 with effective immunoregulation functions. Immunology. 2005·Dec; 116(4):487‑98. <·PMID:·16313362·> | Recio MJ, Moreno-Pelayo MA, Kiliç SS, Guardo AC, Sanal O, Allende LM, Pérez-Flores V, Mencía A, Modamio-Høybjør S, Seoane E, Regueiro JR: Differential biological role of CD3 chains revealed by human immunodeficiencies. J·Immunol. 2007·Feb·15; 178(4):2556‑64. <·PMID:·17277165·> | Guttman-Yassky E, Vugmeyster Y, Lowes MA, Chamian F, Kikuchi T, Kagen M, Gilleaudeau P, Lee E, Hunte B, Howell K, Dummer W, Bodary SC, Krueger JG: Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T‑cell hyporesponsiveness. J·Invest·Dermatol. 2008·May; 128(5):1182‑91. <·PMID:·18239614·>
Available Technical Data Sheets
The stored information can be resent to our servers the next time you visit the website. More information